SELLAS Life Sciences Group (SLS) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

SELLAS Life Sciences Group (SLS) Company Statistics | The Fly

SELLAS Life Sciences Group

· SLS

Dashboard

Financials

Ratios

Valuation

Statistics

2.324 B

+6.95%

General

Market Cap: $2.32B
Enterprise Value: $2.15B
Shares Outstanding: 196,630,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -22.33%
ROE: -35.91%
ROIC: -25.45%
Current Ratio: 18.83
Debt-to-Equity: 0.01
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 16.64
EV/EBITDA: -84.81

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $35.22M
Operating Income: -$35.22M
Net Profit: -$32.46M

Balance Sheet

Cash and Equivalents: $138.44M
Working Capital: $134.94M
Total Assets: $145.38M
Net Debt: -$137.71M
Total Liabilities: $7.73M
Total Equity: $137.66M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$28.42M
Cash Flow from Investing: —
Cash Flow from Financing: $141.47M
Free Cash Flow: -$28.42M
Capital Expenditures: $0